| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.32 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |